Dr. Weiner's laboratory investigative interests focus on the regulation of uterine quiescence during pregnancy, impact of chronic fetal hypoxia, and the discovery, interpretation, and application of biomarkers for reproductive pathology. His laboratory has multiple firsts in the application of proteomics, genomics and transcriptomics to reproductive science. Dr. Weiner is a strong advocate of the strategic linking of clinical and basic research, and is the founder and President of Perinet Inc., a biomedical development company created to facilitate the development of his laboratory's findings.